Categories: News

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Monthly information regarding the total number of voting rights and

total number of shares of the Company as of September 30, 2022

 

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

Date

Total number of shares Total number of voting rights
09/30/2022 94,025,441

Total gross of voting rights: 94,025,441

Total net* of voting rights: 93,888,340

* Total net = total number of voting rights attached to shares – shares without voting rights

 

Attachment

Staff

Recent Posts

Zepp Health Corporation Reports First Quarter 2025 Unaudited Financial Results

MILPITAS, Calif., May 19, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE:…

58 minutes ago

Community Hospital of Anaconda Notifies Individuals of Data Security Incident

ANACONDA, Mont., May 19, 2025 /PRNewswire/ -- Community Hospital of Anaconda ("CHA") is providing notice…

7 hours ago

Teal Health Announces Publication of SELF-CERV Study Results in JAMA Network Open Following FDA Approval of Teal Wand™ for At-Home HPV Screening

SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- Following its recent FDA approval, Teal Health® announced the…

7 hours ago

BI2 Technologies and Support Our Sheriffs Foundation partner with SingleCare to create Sheriff Rx

Free program will provide access to affordable medications to Sheriffs' employees across the nation PLYMOUTH,…

7 hours ago

UCB and Domino Data Lab Collaborate to Modernize Statistical Computing Environment in Life Sciences

Collaboration Blends Advanced Cloud Technologies, Open-Source Collaboration, and Data Science Integration to support UCB's development pipeline…

7 hours ago

Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding

AI-driven robotics platform reduces drug formulation development time from years to months SACRAMENTO, Calif., May…

7 hours ago